Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Karo Bio initiates phase IIb clinical study of KB-2115 for dyslipidemia

Nov. 19, 2007

New data for mipomersen in routine high cholesterol patients

Nov. 19, 2007

Final positive results announced from phase II GHRH trial

Nov. 19, 2007

Combination therapy with lapaquistat and atorvastatin improves hypercholesterolemia

Nov. 19, 2007

Recent GSK patent discloses new therapeutic agents for cachexia

Nov. 16, 2007

Pfizer and Nektar confirm Exubera and inhaled insulin product agreement

Nov. 16, 2007

New therapeutic agents for metabolic disorders described in recent patents

Nov. 16, 2007

Fastic/Starsis receives approval for supplemental NDA in Japan

Nov. 15, 2007

FDA approves Mircera for renal anemia indication

Nov. 15, 2007

SEACOAST study reveals efficacy of Simcor in dyslipidemia

Nov. 15, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...